Androgenic Alopecia Treatment
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Millions of people globally experience some form of hair loss, which typically increases with age. Pattern baldness, also known as androgenic alopecia (AGA), is the leading type, affecting more than half of men over 50 and a significant portion…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Minoxidil is a clinically proven hair-regrowth agent that is one of only two FDA-approved treatments for pattern hair loss. It has consistently yielded favorable outcomes for millions of men worldwide, and its effectiveness is supported by decades of study…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Today’s market is saturated with hair-loss products for women, and navigating advertising claims to find effective treatments can be challenging. Top products demonstrate proven efficacy and safety with customization features and affordability to suit a range of female hair-restoration…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Testosterone replacement therapy (TRT) can be a breakthrough for men with low testosterone levels. It has been shown to boost vitality, sexual function, muscle mass, and energy levels once lost to hormonal decline. However, this life-changing intervention is often…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. Many Follicle Thought readers will have likely tried or are taking different pharmaceutical treatments for hair loss. Some might be disappointed by the regrowth achieved, and others may have responded exceptionally well, seeing dramatic results in a short period…
Commissions we earn from partner links on this page do not affect our opinions or evaluations. This isn’t news about future treatments. Instead, this is about a new U.S.-based telehealth brand, Ulo, and its innovative prescription and over-the-counter treatments for hair growth. There are dozens of telehealth hair care brands, yet Follicle Thought has never…
Pelage Pharmaceuticals has announced topline results from its Phase 2a trial of PP405, a new topical aimed at reactivating dormant hair follicle stem cells to treat androgenic alopecia (AGA). While the data show promise for a regenerative approach, there are important limitations and open questions to keep in mind. The Study The Phase 2a study…
More news is coming out of Kintor Pharma this month. Kintor Pharma (HKEX: 9939) has announced that its observational study evaluating the combination of KX-826 and minoxidil for the treatment of androgenetic alopecia (AGA) in adult males in China has successfully reached its primary endpoint. This marks another milestone in the development of KX-826, following…
Atticus Pharma, a clinical-stage biopharmaceutical company specializing in immunodermatology treatments, has announced the initiation of its first human clinical trial of ATC-002 for androgenic alopecia. What is Atticus Pharma? Atticus Pharma was founded in 2024 to develop pharmaceutical applications of its proprietary Z-pod® technology, a sustained-release drug delivery platform designed to improve treatment outcomes in…
There is more news in the androgenic alopecia space, as Eirion Therapeutics begins a Phase 1 trial for ET-02, a topical treatment. What is ET-02? According to Eirion Therapeutics, ET-02 works by targeting hair follicle stem cells that have become defective or inactive in individuals suffering from androgenic alopecia, enabling hair follicles to resume normal…